Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy
Articolo
Data di Pubblicazione:
2021
Citazione:
Crea, F., Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy, <>, 2021; 42 (31): 2973-2985. [doi:10.1093/eurheartj/ehab277] [http://hdl.handle.net/10807/204471]
Abstract:
N/A
Tipologia CRIS:
Articolo in rivista, Nota a sentenza
Keywords:
Clopidogrel; Humans; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Ticagrelor; Percutaneous Coronary Intervention
Elenco autori:
Crea, Filippo
Link alla scheda completa:
Pubblicato in: